News

Candidate PMR Criteria Are a Work in Progress


 

▸ Step 4, the final stage in the diagnostic process, is follow-up at 4-6 weeks to make sure no alternative diagnoses have come to the fore.

When it comes to distinguishing PMR from seronegative arthropathies, there are two useful clues. First, keep in mind that synovitis of more than 6 weeks' duration is more likely to be an inflammatory arthropathy. Second, a patient who has both bilateral shoulder pain and bilateral hip pain is more likely to have PMR, Dr. Dasgupta said in response to a question from the audience.

But when it's really tough to make the distinction, the most practical issue is simply whether the patient in question responds to low-dose steroids.

“If a patient like this hasn't responded to 5 or 6 weeks of prednisone at 15-20 mg/day, you—d probably want to consider starting a DMARD,” he said.

Disclosures: Dr. Dasgupta's study is funded by grants from both the ACR and EULAR.

'We have a group of patients …who are currently unclassifiable. So we need to do more work.'

Source DR. DASGUPTA

Pages

Recommended Reading

Many With Foot, Ankle Pain Drop Out of Care : Despite wide prevalence, it remains unclear that the condition is due to musculoskeletal ills.
MDedge Rheumatology
Foot Care Falls Short in RA, Despite High Pathology Rate
MDedge Rheumatology
Elderly Receive Suboptimal RA Treatment
MDedge Rheumatology
RA Patients on the Frontier Of Joint Replacement
MDedge Rheumatology
Framingham Approach Needed in Back Pain
MDedge Rheumatology
TNF Inhibitor Significantly Slowed RA Progression
MDedge Rheumatology
RA Subset Responds to Higher Rituximab Dose
MDedge Rheumatology
ACR/EULAR Criteria Found Valid at 2 Years
MDedge Rheumatology
Biologics Highlighted in Joint AS Guidelines : ASAS and EULAR collaborated to revise this document on ankylosing spondylitis management.
MDedge Rheumatology
New Score Aims to Improve AS Evaluation and Care
MDedge Rheumatology